Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

Abstract

Memory T cells promote allograft rejection particularly in co-stimulation blockade–based immunosuppressive regimens. Here we show that the CD2-specific fusion protein alefacept (lymphocyte function–associated antigen-3–Ig; LFA -3–Ig) selectively eliminates memory T cells and, when combined with a co-stimulation blockade–based regimen using cytotoxic T lymphocyte antigen-4 (CTLA-4)-Ig, a CD80- and CD86-specific fusion protein, prevents renal allograft rejection and alloantibody formation in nonhuman primates. These results support the immediate translation of a regimen for the prevention of allograft rejection without the use of calcineurin inhibitors, steroids or pan–T cell depletion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The effect of LFA-3–Ig on renal allograft survival and memory T cells in rhesus macaques.
Figure 2: Studies investigating the relationship between CD2 expression and alloresponsiveness in MLC as measured by proliferation and cytokine production.

Similar content being viewed by others

References

  1. Meier-Kriesche, H.U. et al. Am. J. Transplant. 6, 1111–1131 (2006).

    Article  CAS  Google Scholar 

  2. Lin, H. et al. J. Exp. Med. 178, 1801–1806 (1993).

    Article  CAS  Google Scholar 

  3. Li, Y., Zheng, X.X., Li, X.C., Zand, M.S. & Strom, T.B. Transplantation 66, 1387–1388 (1998).

    Article  CAS  Google Scholar 

  4. Kirk, A.D. et al. Immunol. Rev. 196, 176–196 (2003).

    Article  CAS  Google Scholar 

  5. Valujskikh, A. & Li, X.C. J. Am. Soc. Nephrol. 18, 2252–2261 (2007).

    Article  CAS  Google Scholar 

  6. Adams, A.B. et al. J. Clin. Invest. 111, 1887–1895 (2003).

    Article  CAS  Google Scholar 

  7. Wu, Z. et al. Nat. Med. 10, 87–92 (2004).

    Article  CAS  Google Scholar 

  8. Ortonne, J.P., Lebwohl, M., Em Griffiths, C. & Alefacept Clinical Study Group Eur. J. Dermatol. 13, 117–123 (2003).

    CAS  PubMed  Google Scholar 

  9. Ellis, C.N., Krueger, G.G. & Alefacept Clinical Study Group N. Engl. J. Med. 345, 248–255 (2001).

    Article  CAS  Google Scholar 

  10. Chamian, F. et al. Proc. Natl. Acad. Sci. USA 102, 2075–2080 (2005).

    Article  CAS  Google Scholar 

  11. Pitcher, C.J. et al. J. Immunol. 168, 29–43 (2002).

    Article  CAS  Google Scholar 

  12. Preston, E.H. et al. Am. J. Transplant. 5, 1032–1041 (2005).

    Article  CAS  Google Scholar 

  13. Girlanda, R. et al. Am. J. Transplant. 8, 600–607 (2008).

    Article  CAS  Google Scholar 

  14. Harari, A. et al. Immunol. Rev. 211, 236–254 (2006).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was funded in part by the Division of Intramural Research, National Institute of Diabetes, Digestive and Kidney Disease, NIH (Z01 DK062007-06). Salary support for T.A.W. was provided by the Howard Hughes Medical Institute through the NIH Research Scholars Program. A.D.K. is supported by the National Institutes of Health (1U01AI079223-01A1), the Georgia Research Alliance and the McKelvey Foundation. We gratefully acknowledge the expert assistance of J. Bacher and the staff of the NIH Veterinary Pathology Department.

Author information

Authors and Affiliations

Authors

Contributions

T.A.W. performed surgical procedures, cared for experimental macaques, conducted in vitro experiments, interpreted data and prepared the manuscript; A.H.C. performed surgical procedures and cared for experimental macaques; A.A. performed surgical procedures, cared for experimental macaques, conducted in vitro experiments and interpreted data; A.P.T. performed surgical procedures, cared for experimental macaques, conducted in vitro experiments and interpreted data; M.R. cared for experimental macaques, conducted in vitro experiments and interpreted data; F.V.L. performed surgical procedures and cared for experimental macaques; R.L.K. conducted in vitro experiments and interpreted data; L.S. conducted in vitro experiments and interpreted data;, M.S. performed histology and immunohistochemistry, interpreted data and prepared the manuscript; C.P.L. interpreted data and prepared the manuscript; A.D.K. conceived of experimental design, performed surgical procedures, cared for experimental macaques, interpreted data and prepared the manuscript.

Corresponding author

Correspondence to Allan D Kirk.

Supplementary information

Supplementary Text and Figures

Supplementary Table 1, Supplementary Figs. 1–4 and Supplementary Methods (PDF 6015 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weaver, T., Charafeddine, A., Agarwal, A. et al. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat Med 15, 746–749 (2009). https://doi.org/10.1038/nm.1993

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.1993

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing